NCT06689358View on ClinicalTrials.gov

Thoracic Paravertebral Block for Postoperative Pain Management After VATS

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
Pain, Postoperative
Interventions
DRUG

0.4 ml/kg of 0.5% bupivacaine

0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space

Trial Locations (1)

11941

King Hussein Cancer Center, Amman

All Listed Sponsors
lead

King Hussein Cancer Center

OTHER